Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maegan L Capitano

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Science Translational Medicine|September 5, 2014
The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantationDaniel J Weber, Adam S A Gracon, Matthew S Ripsch, et al.
Cancer Research Communications|September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for OsteosarcomaEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Nature Communications|July 30, 2020
Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.
Nature Communications|December 13, 2019
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.
The Journal of Clinical Investigation|December 30, 2025
Mutant p53 promotes clonal hematopoiesis through generating a chronic inflammatory microenvironmentSisi Chen, Sergio Barajas, Sasidhar Vemula, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Science Translational Medicine|September 5, 2014
The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantationDaniel J Weber, Adam S A Gracon, Matthew S Ripsch, et al.
Cancer Research Communications|September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for OsteosarcomaEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Nature Communications|July 30, 2020
Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.
Nature Communications|December 13, 2019
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.
The Journal of Clinical Investigation|December 30, 2025
Mutant p53 promotes clonal hematopoiesis through generating a chronic inflammatory microenvironmentSisi Chen, Sergio Barajas, Sasidhar Vemula, et al.
Pageof 5